Healthcare Innovation Stocks
Biopharmaceutical and medical technology firms in this cohort focus on the commercialization of novel therapeutic platforms, ranging from targeted oncology and rare disease gene therapies to neuromodulation and AI-driven diagnostics.
As of Oct 23, 2026, Healthcare Innovation has 50 US-listed companies worth $291B combined. The median member moved +2.4% over the past week; MANE led among the 25 largest at +27.5% and SCTX trailed at -23.3%.
Companies in Healthcare Innovation
- ISRG – Intuitive Surgical Inc, $160B
- EW – Edwards Lifesciences Corp, $51.9B
- TEM – Tempus AI, Inc. Class A Common Stock, $12.3B
- GKOS – Glaukos Corp, $10.4B
- PODD – Insulet Corporation, $10.3B
- IBRX – Immunitybio Inc, $8.8B
- HIMS – Hims Hers Health Inc, $6.8B
- MANE – Veradermics, Incorporated, $5.8B
- ABCL – Abcellera Biologics Inc, $3.8B
- PLSE – Pulse Biosciences Inc, $3.7B
- ALMR – Alamar Biosciences, Inc. Common Stock, $2B
- RXRX – Recursion Pharmaceuticals Inc, $1.9B
- BFLY – Butterfly Network Inc, $1.8B
- GHRS – GH Research PLC, $1.3B
- STAA – STAAR Surgical Company, $1.1B
- TDOC – Teladoc Inc, $1B
- SPTX – Seaport Therapeutics, Inc. Common Stock, $986M
- CBLL – CeriBell, Inc, $888M
- HELP – Cybin Inc., $799M
- OBX – Obsidian Therapeutics, Inc. Common Stock, $741M
- STLN – The Oncology Institute, Inc., $655M
- DCTH – Delcath Systems Inc, $534M
- EIKN – Eikon Therapeutics, Inc. Common Stock, $408M
- RCEL – Avita Medical Ltd, $404M
- SCTX – Scribe Therapeutics Inc. Common Stock, $380M
- OBIO – Orchestra BioMed Holdings Inc., $358M
- MOBI – Mobia Medical, Inc. Common Stock, $287M
- MOVE – Movano Inc, $276M
- PROF – Profound Medical Corp, $242M
- MSLE – Satellos Bioscience Inc. Common Stock, $145M
- LUCD – Lucid Diagnostics Inc, $116M
- RANI – Rani Therapeutics Holdings Inc, $103M
- HYPR – Hyperfine Inc, $98.7M
- NRXS – Neuraxis, Inc., $87M
- OM – Outset Medical Inc, $79.1M
- MBOT – Microbot Medical Inc, $71.9M
- COCH – Envoy Medical Inc., $50.9M
- CRVO – CervoMed Inc., $35.4M
- AIFF – Firefly Neuroscience, Inc., $16M
- ICU – SeaStar Medical Holding Corporation, $15.3M
- BNGO – Bionano Genomics Inc, $14.4M
- ACON – Aclarion Inc, $6.1M
- VNRX – Volitionrx Ltd, $5.4M
- ADXN – Addex Therapeutics Ltd, $5.4M
- PPCB – Propanc Biopharma, Inc. Common Stock, $4.8M
- NIKI – Niki BioSolutions, Inc., $3.7M
- BJDX – Bluejay Diagnostics Inc, $3.3M
- VBIO – Valion Bio Inc, $2.2M
- MNDR – Mobile-health Network Solutions Class A Ordinary Shares, $1.1M
- RBOT – Vicarious Surgical Inc., $392,224